Product NDC: | 0338-0411 |
Proprietary Name: | Lidocaine Hydrochloride and Dextrose |
Non Proprietary Name: | Lidocaine Hydrochloride |
Active Ingredient(s): | 8 mg/mL & nbsp; Lidocaine Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-0411 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018461 |
Marketing Category: | NDA |
Start Marketing Date: | 19810422 |
Package NDC: | 0338-0411-02 |
Package Description: | 250 mL in 1 BAG (0338-0411-02) |
NDC Code | 0338-0411-02 |
Proprietary Name | Lidocaine Hydrochloride and Dextrose |
Package Description | 250 mL in 1 BAG (0338-0411-02) |
Product NDC | 0338-0411 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lidocaine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19810422 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | LIDOCAINE HYDROCHLORIDE |
Strength Number | 8 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |